Doctors recommend finasteride to lower prostate cancer risk

02/24/2009 | Washington Post (tiered subscription model), The · Google

The American Society of Clinical Oncology and the American Urological Association issued guidelines suggesting that the drug finasteride could reduce by as much as 25% the risk of prostate cancer in middle-age men who undergo regular screening. The drug, which is used to treat urinary problems and male pattern baldness, has been found to shrink the prostate and lower testosterone, which can contribute to cancer growth.

View Full Article in:

Washington Post (tiered subscription model), The · Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN